Skip to main content
. 2015 Mar 16;10(3):e0120365. doi: 10.1371/journal.pone.0120365

Table 4. Analysis of association of the 27 SNPs gene polymorphism with the risk of KBD a .

Gene/SNP Genotype model b Dominant model Recessive model Allele model c
AA AB BB
OR (95% CI) OR (95% CI) OR OR (95% CI) OR (95% CI) OR (95% CI)
COL9A1
rs592121 1.05(0.54–2.02) 0.98 (0.67–1.43) 1.00 1.04(0.74–1.48) 1.26(0.69–2.30) 1.01(0.76–1.32)
rs1064250 0.60 (0.22–1.64) 1.19(0.82–1.75) 1.00 1.12(0.78–1.59) 1.20 (0.83–1.72) 1.03 (0.75–1.40)
rs1135056 0.73 (0.36–1.50) 1.25(0.86–1.82) 1.00 0.99(0.70–1.40) 2.13(1.17–3.82) d 1.12 (0.85–1.46)
rs2274584 1.08 (0.50–2.34) 1.27(0.85–1.87) 1.00 1.21(0.85–1.73) 1.04 (0.50–2.18) 1.16 (0.85–1.57)
rs3806099 1.14 (0.59–2.18) 0.99(0.68–1.45) 1.00 1.08(0.76–1.52) 1.36 (0.75–2.47) 1.04 (0.78–1.36)
rs519068 0.94 (0.46–1.97) 1.19(0.82–1.73) 1.00 1.26(0.89–1.78) 1.02 (0.51–2.05) 1.07 (0.81–1.42)
rs617600 0.23 (0.04–1.21) 1.04(0.69–1.59) 1.00 1.01(0.68–1.50) 0.30 (0.06–1.49) 0.89 (0.61–1.28)
rs617985 0.23 (0.04–1.21) 1.04(0.68–1.58) 1.00 1.01(0.68–1.49) 0.30 (0.06–1.48) 0.88 (0.61–1.28)
rs679521 0.66 (0.39–1.09) 0.85 (0.56–1.32) 1.00 0.84(0.57–1.23) 0.78 (0.52–1.16) 0.81 (0.63–1.05)
rs6928611 0.00 (0.00-/) 0.83(0.51–1.34) 1.00 0.80(0.51–1.26) 0.87 (0.55–1.37) 0.73 (0.47–1.14)
rs2072650 0.56 (0.08–3.85) 1.25(0.81–1.93) 1.00 1.23(0.82–1.86) 0.61 (0.10–3.65) 1.15 (0.77–1.70)
rs12210870 0.00 (0.00-/) 1.55(0.83–2.92) 1.00 1.64(0.89–3.01) 1.58 (0.86–2.91) 1.60 (0.87–2.94)
rs6910140 0.48 (0.16–1.47) 0.71(0.47–1.05) 1.00 0.49(0.34–0.70) e 0.37(0.13–1.05) 0.73 (0.52–1.01)
rs883708 0.59 (0.15–2.35) 1.07(0.70–1.64) 1.00 1.08 (0.73–1.61) 0.73 (0.19–2.73) 1.01 (0.68–1.43)
rs616642 0.23 (0.04–1.21) 1.03 (0.67–1.60) 1.00 1.09 (0.72–1.63) 0.30 (0.06–1.48) 0.87 (0.59–1.27)
COL9A2
rs12077871 0.50 (0.08–3.09) 0.85(0.55–1.32) 1.00 0.88 (0.58–1.32) 0.61 (0.10–3.68) 0.83 (0.56–1.23)
rs2076696 1.56 (0.69–3.51) 1.22(0.84–1.77) 1.00 1.25 (0.88–1.77) 1.12 (0.53–2.37) 1.22 (0.91–1.64)
rs209923 0.94 (0.54–1.66) 0.86 (0.58–1.26) 1.00 0.95 (0.67–1.34) 1.07 (0.64–1.78) 0.94 (0.72–1.22)
rs1983658 0.71 (0.41–1.22) 0.76(0.51–1.14) 1.00 0.81 (0.57–1.16) 0.92 (0.57–1.48) 0.82 (0.63–1.07)
rs3737821 0.44 (0.03–5.57) 0.88(0.54–1.41) 1.00 0.86 (0.55–1.36) 0.45 (0.04–4.99) 0.85 (0.55–1.32)
rs2075560 1.34 (0.45–4.02) 0.86 (0.57–1.30) 1.00 0.93 (0.63–1.37) 1.36 (0.48–3.87) 0.96 (0.67–1.36)
rs2273195 1.28(0.48–3.39) 0.83 (0.55–1.23) 1.00 0.90 (0.62–1.30) 1.38 (0.55–3.43) 0.93 (0.67–1.29)
rs2228567 0.99 (0.00-/) 0.9 (0.61–1.12) 1.00 1.08 (0.68–1.72) 1.03 (0.64–1.64) 1.07 (0.68–1.69)
COL9A3
rs2249766 1.58 (0.78–3.23) 1.37 (0.94–2.01) 1.00 1.36 (0.96–1.93) 1.28 (0.66–2.50) 1.32 (0.99–1.77)
rs3765462 0.77 (0.21–2.85) 1.59(1.05–2.42) d 1.00 1.35 (0.91–1.98) 0.51 (0.15–1.78) 1.34 (0.94–1.92)
rs741758 1.36 (0.54–4.13) 0.81 (0.55–1.22) 1.00 0.88 (0.61–1.27) 1.84 (0.62–5.46) 0.92 (0.66–1.29)
rs760087 1.11 (0.64–1.91) 0.79 (0.54–1.81) 1.00 0.87 (0.61–1.25) 1.35 (0.84–2.17) 1.03 (0.77–1.29)

a Adjusted for age and gender;

b AB stands for the minor/major alleles, BB as the reference genotype;

c Major allele as the reference allele;

d The significance did not remain after correction for multiple testing;

e The significance remained after correction for multiple testing.